GlassScriptPhysician profile
Vinod K Sinha
NPI 1619035037
$2,194.45
in general payments reported to CMS, 2019-2025
16 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $401 · 2022: $394 · 2023: $629 · 2024: $331 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $784.25 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Glaxosmithkline, LLC. | $288.12 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $252.70 | 2021-2023 | |
| Novo Nordisk INC | $245.81 | 2019-2025 | Ozempic, Rybelsus |
| Insmed, INC. | $190.02 | 2021-2023 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.38 | 2021 | |
| Genzyme Corporation | $103.73 | 2024-2025 | |
| Abbott Laboratories | $42.10 | 2022-2023 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $30.16 | 2022 | |
| Xeris Pharmaceuticals, INC. | $29.50 | 2023 | Gvoke Hypopen |
| Baxter Healthcare | $20.19 | 2025 | Hillrom - Monarch Airway Clearance System |
| Mylan Specialty L.P. | $19.43 | 2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $19.42 | 2024 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $18.73 | 2024 | Veklury |
| Regeneron Healthcare Solutions, INC. | $16.06 | 2023 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $14.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.